Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DE:5IU
Stock Latest News
Company Announcements
Isofol Showcases Arfolitixorin Trial Design at ASCO GI as Phase Ib/II Study Advances
1M ago
Premium
Company Announcements
Isofol Medical to Showcase Arfolitixorin at Upcoming Investor Meetings
3M ago
Premium
Company Announcements
Isofol Medical Secures New Patent for Cancer Drug Candidate Arfolitixorin
3M ago
Premium
Company Announcements
Isofol Medical AB Reports Key Developments in Interim Report
3M ago
Premium
Company Announcements
Isofol Medical AB Appoints Nomination Committee for 2026 AGM
4M ago
Premium
Company Announcements
Isofol Medical AB to Host Investor Meeting on Arfolitixorin Progress
4M ago
Premium
Company Announcements
Isofol Medical AB to Present at ESMO Cancer Congress
4M ago
Premium
Company Announcements
Isofol Medical Advances Arfolitixorin Clinical Study with Promising Results
5M ago
Premium
Company Announcements
Isofol Completes Share Transfer to Solasia Pharma, Strengthening Partnership
5M ago
Premium
Company Announcements
Isofol Medical AB Strengthens Financial Position Amid Ongoing Clinical Developments
6M ago
Premium
Company Announcements
Isofol Medical to Present Q2 2025 Interim Report
6M ago
Premium
Company Announcements
Isofol Medical Announces Change in Shares and Votes
7M ago
Premium
Company Announcements
Isofol Medical Secures FDA Support for Arfolitixorin Development
7M ago
Premium
Company Announcements
Isofol Medical’s Rights Issue Fully Subscribed, Boosting Financial Position
8M ago
Premium
Company Announcements
Isofol Medical AB Announces Fully Guaranteed Rights Issue
8M ago
Premium
Company Announcements
Isofol Medical Advances Arfolitixorin Clinical Study
8M ago
Premium
Company Announcements
Isofol Medical AB Approves New Share and Warrant Issue to Bolster Financial Position
8M ago
Premium
Company Announcements
Isofol Medical AB Announces Final Terms for Rights Issue to Fund Expanded Cancer Study
9M ago
Premium
Company Announcements
Isofol Medical Launches New Advisory Board at ASCO 2025
9M ago
Premium
Company Announcements
Isofol Medical Secures FDA Pre-IND Meeting for Arfolitixorin
9M ago
Premium
Company Announcements
Isofol Medical AB AGM Resolutions and Future Plans
9M ago
Premium
Company Announcements
Isofol Medical AB Advances Arfolitixorin Development Amid Financial Strategies
9M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.